deltatrials
Unknown NA NCT00929318

Influence of Thyroid Hormones on the Woundhealing Process

Clinical Investigations on Cytokin-Gradients in Hypo/Euthyroid Patients. Evaluation of Expression of Different Pro-and Anti-Inflammatory Cyto-/Chemokines in Skin Wounds After Surgery of Benign Goitres (Struma Multinodosa) or Malignant Diseases of Thyroid Gland (Papillary Thyroid Carcinoma) in Correlation to the Status of Wound Healing of the Neck Wound

Sponsor: Genzyme, a Sanofi Company

Conditions Thyroid Carcinoma Thyroid Neoplasms
Interventions blood sampling
Updated 5 times since 2017 Last updated: Jun 26, 2009 Started: Jun 30, 2009 Primary completion: Dec 31, 2009 Completion: Apr 30, 2010

Listed as NCT00929318, this NA trial focuses on Thyroid Carcinoma and Thyroid Neoplasms and remains ongoing. Sponsored by Genzyme, a Sanofi Company, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  5. Jan 2017 — Jan 2021 [monthly]

    Unknown Status NA

    First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Genzyme, a Sanofi Company
  • Hannover Medical School
Data source: Hannover Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Hanover, Germany